More Triple-Leveraged Biotech ETFs Come to Town
June 23, 2015 at 12:30 PM EDT
For over five years, the ProShares Ultrashort Nasdaq Biotechnology (NasdaqGM: BIS) and the ProShares Ultra Nasdaq Biotechnology (NasdaqGM: BIB) cornered the market for leveraged biotechnology exchange traded funds. In the span of three weeks, the number of leveraged biotech ETFs has tripled. In...
